Volumen Plaquetario Medio Como Predictor de Eventos Cardiovasculares Mayores y Flujo Coronario Final en Pacientes Sometidos a Intervención Coronaria Percutánea Primaria

7_luiz_carlos_corsetti_bergoli_articulo
Luiz Carlos Corsetti Bergoli, Eliza Schuck Castanho, Sandro Cadaval Gonçalves, Rodrigo V. Wainstein, Diogo Piardi, Gustavo Araújo, Márcio Mossmann, Ana Maria Krepsky, Marco V. Wainstein

More articles by this author

[Caso Clínico] Presentación Atípica de Hematoma Intramural de la Aorta Ascendente con Tratamiento Conservador

Claudia Maria Rodrigues Alves, Manuel Pereira Marques Gomes Jr., Ricardo Peressoni Faraco, Tatiana Sawabini, Paulo Cézar Ferraz Dias Filho, Hilton Muniz Leão Filho

[Caso Clínico] Arteria Coronaria Derecha Originada de la Arteria Descendente Anterior: Una Rara Anomalía Coronaria

Mário Barbosa Guedes Nunes, Samir Ibrahim Duarte, Rafael Alexandre Meneguz Moreno, Antonio de Castro Filho, Edgar Stroppa Lamas, Sérgio Navarro Braga

Coartación de Aorta en Niños con Menos de 25 kg: Tratamiento Percutáneo Mediante Punción de la Arteria Axilar

Germana Coimbra, Elio Vitor Duarte, Luiz J. Kajita, Pedro Lemos, Raul Arrieta

Relación Balón/Arteria y Volumen de Obstrucción Neointimal después de Implante de Stent Liberador de Zotarolimus

Gustavo do Prado Monteiro, J. Ribamar Costa Jr., Carlos Collet, Juliano Slhessarenko, Fausto Feres, Ricardo Costa, Áurea J. Chaves, Marinella Centemero, Amanda G.M.R. Sousa,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...